The recent disruptions in global chains have highlighted the importance of securing critical medications like Ivermectin. Dependence on overseas manufacturers exposes regions to potential vulnerabilities, including transportation delays, cost fluctuations, and even geopolitical concerns. Transitioning towards domestic production of Ivermectin offer